Lineage, Inc. Common Stock (LINE)vsUDR Inc (UDR)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
UDR
UDR Inc
$35.12
-0.06%
REAL ESTATE · Cap: $13.38B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 204% more annual revenue ($5.37B vs $1.77B). UDR leads profitability with a 29.6% profit margin vs -3.1%. UDR earns a higher WallStSmart Score of 59/100 (C).
LINE
Avoid35
out of 100
Grade: F
UDR
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+29.6%
Fair Value
$56.50
Current Price
$35.12
$21.38 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 90.9% YoY
Keeps 30 of every $100 in revenue as profit
Strong operational efficiency at 20.2%
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Expensive relative to growth rate
Revenue declined 0.1%
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : UDR
The strongest argument for UDR centers on EPS Growth, Profit Margin, Operating Margin. Profitability is solid with margins at 29.6% and operating margin at 20.2%.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : UDR
The primary concerns for UDR are PEG Ratio, Revenue Growth, Altman Z-Score. Debt-to-equity of 2.04 is elevated, increasing financial risk.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while UDR is a declining play — different risk/reward profiles.
LINE carries more volatility with a beta of 0.88 — expect wider price swings.
LINE is growing revenue faster at 0.8% — sustainability is the question.
UDR generates stronger free cash flow (200M), providing more financial flexibility.
Bottom Line
UDR scores higher overall (59/100 vs 35/100), backed by strong 29.6% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →UDR Inc
REAL ESTATE · REIT - RESIDENTIAL · USA
UDR Inc. is a publicly traded real estate investment trust that invests in apartments. The company is organized in Maryland with its headquarters in Highlands Ranch, Colorado.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?